Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Hormonal Therapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Hormonal Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Hormonal Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
ALZA Corporation (USA)
Immunomedics, Inc. (USA)
Amgen Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)
Progenics Pharmaceuticals, Inc. (USA)
Genentech Inc. (USA)
Mylan Laboratories Inc. (USA)
Bayer (USA)
EUSA Pharma, (USA) Inc. (USA)
Sanofi-Aventis SA (France)
OSI Pharmaceuticals, Inc. (USA)
Abbott Laboratories AG (Switzerland)
Spectrum Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
AstraZeneca PLC (UK)
Bristol-Myers Squibb Company (USA)
Indevus Pharmaceuticals Inc. (USA)
Cell Genesys Inc. (USA)
Medimmune, LLC (USA)
GlaxoSmithKline Plc (UK)
F. Hoffmann-La Roche Ltd. (Switzerland)
Dendreon Corporation (USA)
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hormonal Therapy Market
-
1.3 Market Segment by Type
1.3.1 Japan Hormonal Therapy Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Hormonal Therapy Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Hormonal Therapy Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Hormonal Therapy Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Hormonal Therapy Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Hormonal Therapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Hormonal Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hormonal Therapy by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Hormonal Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hormonal Therapy by Major End-Users
4.4.1 Market Size and Growth Rate of Hormonal Therapy in Application 1
4.4.2 Market Size and Growth Rate of Hormonal Therapy in Application 2
4.4.3 Market Size and Growth Rate of Hormonal Therapy in Application 3
5 Market Analysis by Regions
-
5.1 Japan Hormonal Therapy Production Analysis by Regions
-
5.2 Japan Hormonal Therapy Consumption Analysis by Regions
6 Hokkaido Hormonal Therapy Landscape Analysis
-
6.1 Hokkaido Hormonal Therapy Landscape Analysis by Major Types
-
6.2 Hokkaido Hormonal Therapy Landscape Analysis by Major End-Users
7 Tohoku Hormonal Therapy Landscape Analysis
-
7.1 Tohoku Hormonal Therapy Landscape Analysis by Major Types
-
7.2 Tohoku Hormonal Therapy Landscape Analysis by Major End-Users
8 Kanto Hormonal Therapy Landscape Analysis
-
8.1 Kanto Hormonal Therapy Landscape Analysis by Major Types
-
8.2 Kanto Hormonal Therapy Landscape Analysis by Major End-Users
9 Chubu Hormonal Therapy Landscape Analysis
-
9.1 Chubu Hormonal Therapy Landscape Analysis by Major Types
-
9.2 Chubu Hormonal Therapy Landscape Analysis by Major End-Users
10 Kinki Hormonal Therapy Landscape Analysis
-
10.1 Kinki Hormonal Therapy Landscape Analysis by Major Types
-
10.2 Kinki Hormonal Therapy Landscape Analysis by Major End-Users
11 Chugoku Hormonal Therapy Landscape Analysis
-
11.1 Chugoku Hormonal Therapy Landscape Analysis by Major Types
-
11.2 Chugoku Hormonal Therapy Landscape Analysis by Major End-Users
12 Shikoku Hormonal Therapy Landscape Analysis
-
12.1 Shikoku Hormonal Therapy Landscape Analysis by Major Types
-
12.2 Shikoku Hormonal Therapy Landscape Analysis by Major End-Users
13 Kyushu Hormonal Therapy Landscape Analysis
-
13.1 Kyushu Hormonal Therapy Landscape Analysis by Major Types
-
13.2 Kyushu Hormonal Therapy Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 ALZA Corporation (USA)
14.1.1 ALZA Corporation (USA) Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Immunomedics, Inc. (USA)
14.2.1 Immunomedics, Inc. (USA) Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Amgen Inc. (USA)
14.3.1 Amgen Inc. (USA) Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Takeda Pharmaceutical Company Limited (Japan)
14.4.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Progenics Pharmaceuticals, Inc. (USA)
14.5.1 Progenics Pharmaceuticals, Inc. (USA) Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Genentech Inc. (USA)
14.6.1 Genentech Inc. (USA) Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Mylan Laboratories Inc. (USA)
14.7.1 Mylan Laboratories Inc. (USA) Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Bayer (USA)
14.8.1 Bayer (USA) Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 EUSA Pharma, (USA) Inc. (USA)
14.9.1 EUSA Pharma, (USA) Inc. (USA) Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Sanofi-Aventis SA (France)
14.10.1 Sanofi-Aventis SA (France) Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 OSI Pharmaceuticals, Inc. (USA)
14.11.1 OSI Pharmaceuticals, Inc. (USA) Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Abbott Laboratories AG (Switzerland)
14.12.1 Abbott Laboratories AG (Switzerland) Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Spectrum Pharmaceuticals, Inc. (USA)
14.13.1 Spectrum Pharmaceuticals, Inc. (USA) Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 Paladin Labs Inc. (Canada)
14.14.1 Paladin Labs Inc. (Canada) Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 AstraZeneca PLC (UK)
14.15.1 AstraZeneca PLC (UK) Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
14.16 Bristol-Myers Squibb Company (USA)
14.16.1 Bristol-Myers Squibb Company (USA) Company Profile and Recent Development
14.16.2 Market Performance
14.16.3 Product and Service Introduction
14.17 Indevus Pharmaceuticals Inc. (USA)
14.17.1 Indevus Pharmaceuticals Inc. (USA) Company Profile and Recent Development
14.17.2 Market Performance
14.17.3 Product and Service Introduction
14.18 Cell Genesys Inc. (USA)
14.18.1 Cell Genesys Inc. (USA) Company Profile and Recent Development
14.18.2 Market Performance
14.18.3 Product and Service Introduction
14.19 Medimmune, LLC (USA)
14.19.1 Medimmune, LLC (USA) Company Profile and Recent Development
14.19.2 Market Performance
14.19.3 Product and Service Introduction
14.20 GlaxoSmithKline Plc (UK)
14.20.1 GlaxoSmithKline Plc (UK) Company Profile and Recent Development
14.20.2 Market Performance
14.20.3 Product and Service Introduction
14.21 F. Hoffmann-La Roche Ltd. (Switzerland)
14.21.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile and Recent Development
14.21.2 Market Performance
14.21.3 Product and Service Introduction
14.22 Dendreon Corporation (USA)
14.22.1 Dendreon Corporation (USA) Company Profile and Recent Development
14.22.2 Market Performance
14.22.3 Product and Service Introduction
The List of Tables and Figures (Totals 117 Figures and 133 Tables)
Figure Japan Hormonal Therapy Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Hormonal Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Hormonal Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Hormonal Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hormonal Therapy by Different Types from 2014 to 2026
-
Table Consumption Share of Hormonal Therapy by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Hormonal Therapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of Hormonal Therapy by Different End-Users from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Hormonal Therapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Hormonal Therapy Production by Regions
-
Table Japan Hormonal Therapy Production Share by Regions
-
Figure Japan Hormonal Therapy Production Share by Regions in 2014
-
Figure Japan Hormonal Therapy Production Share by Regions in 2018
-
Figure Japan Hormonal Therapy Production Share by Regions in 2026
-
Table Japan Hormonal Therapy Consumption by Regions
-
Table Japan Hormonal Therapy Consumption Share by Regions
-
Figure Japan Hormonal Therapy Consumption Share by Regions in 2014
-
Figure Japan Hormonal Therapy Consumption Share by Regions in 2018
-
Figure Japan Hormonal Therapy Consumption Share by Regions in 2026
-
Table Hokkaido Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Hokkaido Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Hormonal Therapy Consumption Share by Types in 2014
-
Figure Hokkaido Hormonal Therapy Consumption Share by Types in 2018
-
Figure Hokkaido Hormonal Therapy Consumption Share by Types in 2026
-
Table Hokkaido Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Hokkaido Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Hokkaido Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Tohoku Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Tohoku Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Hormonal Therapy Consumption Share by Types in 2014
-
Figure Tohoku Hormonal Therapy Consumption Share by Types in 2018
-
Figure Tohoku Hormonal Therapy Consumption Share by Types in 2026
-
Table Tohoku Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Tohoku Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Tohoku Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Kanto Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Kanto Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto Hormonal Therapy Consumption Share by Types in 2014
-
Figure Kanto Hormonal Therapy Consumption Share by Types in 2018
-
Figure Kanto Hormonal Therapy Consumption Share by Types in 2026
-
Table Kanto Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Kanto Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Kanto Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Kanto Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Chubu Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Chubu Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu Hormonal Therapy Consumption Share by Types in 2014
-
Figure Chubu Hormonal Therapy Consumption Share by Types in 2018
-
Figure Chubu Hormonal Therapy Consumption Share by Types in 2026
-
Table Chubu Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Chubu Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Chubu Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Chubu Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Kinki Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Kinki Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki Hormonal Therapy Consumption Share by Types in 2014
-
Figure Kinki Hormonal Therapy Consumption Share by Types in 2018
-
Figure Kinki Hormonal Therapy Consumption Share by Types in 2026
-
Table Kinki Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Kinki Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Kinki Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Kinki Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Chugoku Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Chugoku Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Hormonal Therapy Consumption Share by Types in 2014
-
Figure Chugoku Hormonal Therapy Consumption Share by Types in 2018
-
Figure Chugoku Hormonal Therapy Consumption Share by Types in 2026
-
Table Chugoku Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Chugoku Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Chugoku Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Shikoku Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Shikoku Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Hormonal Therapy Consumption Share by Types in 2014
-
Figure Shikoku Hormonal Therapy Consumption Share by Types in 2018
-
Figure Shikoku Hormonal Therapy Consumption Share by Types in 2026
-
Table Shikoku Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Shikoku Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Shikoku Hormonal Therapy Consumption Share by End-Users in 2026
-
Table Kyushu Hormonal Therapy Consumption by Types from 2014 to 2026
-
Table Kyushu Hormonal Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Hormonal Therapy Consumption Share by Types in 2014
-
Figure Kyushu Hormonal Therapy Consumption Share by Types in 2018
-
Figure Kyushu Hormonal Therapy Consumption Share by Types in 2026
-
Table Kyushu Hormonal Therapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu Hormonal Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Hormonal Therapy Consumption Share by End-Users in 2014
-
Figure Kyushu Hormonal Therapy Consumption Share by End-Users in 2018
-
Figure Kyushu Hormonal Therapy Consumption Share by End-Users in 2026
Table Company Profile and Development Status of ALZA Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation (USA)
Figure Sales and Growth Rate Analysis of ALZA Corporation (USA)
Figure Revenue and Market Share Analysis of ALZA Corporation (USA)
Table Product and Service Introduction of ALZA Corporation (USA)
Table Company Profile and Development Status of Immunomedics, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (USA)
Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (USA)
Figure Revenue and Market Share Analysis of Immunomedics, Inc. (USA)
Table Product and Service Introduction of Immunomedics, Inc. (USA)
Table Company Profile and Development Status of Amgen Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc. (USA)
Figure Sales and Growth Rate Analysis of Amgen Inc. (USA)
Figure Revenue and Market Share Analysis of Amgen Inc. (USA)
Table Product and Service Introduction of Amgen Inc. (USA)
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited (Japan)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited (Japan)
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited (Japan)
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited (Japan)
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited (Japan)
Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of Progenics Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Genentech Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc. (USA)
Figure Sales and Growth Rate Analysis of Genentech Inc. (USA)
Figure Revenue and Market Share Analysis of Genentech Inc. (USA)
Table Product and Service Introduction of Genentech Inc. (USA)
Table Company Profile and Development Status of Mylan Laboratories Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Laboratories Inc. (USA)
Figure Sales and Growth Rate Analysis of Mylan Laboratories Inc. (USA)
Figure Revenue and Market Share Analysis of Mylan Laboratories Inc. (USA)
Table Product and Service Introduction of Mylan Laboratories Inc. (USA)
Table Company Profile and Development Status of Bayer (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer (USA)
Figure Sales and Growth Rate Analysis of Bayer (USA)
Figure Revenue and Market Share Analysis of Bayer (USA)
Table Product and Service Introduction of Bayer (USA)
Table Company Profile and Development Status of EUSA Pharma, (USA) Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Sales and Growth Rate Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Revenue and Market Share Analysis of EUSA Pharma, (USA) Inc. (USA)
Table Product and Service Introduction of EUSA Pharma, (USA) Inc. (USA)
Table Company Profile and Development Status of Sanofi-Aventis SA (France)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA (France)
Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA (France)
Figure Revenue and Market Share Analysis of Sanofi-Aventis SA (France)
Table Product and Service Introduction of Sanofi-Aventis SA (France)
Table Company Profile and Development Status of OSI Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of OSI Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Abbott Laboratories AG (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories AG (Switzerland)
Figure Sales and Growth Rate Analysis of Abbott Laboratories AG (Switzerland)
Figure Revenue and Market Share Analysis of Abbott Laboratories AG (Switzerland)
Table Product and Service Introduction of Abbott Laboratories AG (Switzerland)
Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Paladin Labs Inc. (Canada)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc. (Canada)
Figure Sales and Growth Rate Analysis of Paladin Labs Inc. (Canada)
Figure Revenue and Market Share Analysis of Paladin Labs Inc. (Canada)
Table Product and Service Introduction of Paladin Labs Inc. (Canada)
Table Company Profile and Development Status of AstraZeneca PLC (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC (UK)
Figure Sales and Growth Rate Analysis of AstraZeneca PLC (UK)
Figure Revenue and Market Share Analysis of AstraZeneca PLC (UK)
Table Product and Service Introduction of AstraZeneca PLC (UK)
Table Company Profile and Development Status of Bristol-Myers Squibb Company (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company (USA)
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company (USA)
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company (USA)
Table Product and Service Introduction of Bristol-Myers Squibb Company (USA)
Table Company Profile and Development Status of Indevus Pharmaceuticals Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc. (USA)
Table Product and Service Introduction of Indevus Pharmaceuticals Inc. (USA)
Table Company Profile and Development Status of Cell Genesys Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc. (USA)
Figure Sales and Growth Rate Analysis of Cell Genesys Inc. (USA)
Figure Revenue and Market Share Analysis of Cell Genesys Inc. (USA)
Table Product and Service Introduction of Cell Genesys Inc. (USA)
Table Company Profile and Development Status of Medimmune, LLC (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune, LLC (USA)
Figure Sales and Growth Rate Analysis of Medimmune, LLC (USA)
Figure Revenue and Market Share Analysis of Medimmune, LLC (USA)
Table Product and Service Introduction of Medimmune, LLC (USA)
Table Company Profile and Development Status of GlaxoSmithKline Plc (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc (UK)
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc (UK)
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc (UK)
Table Product and Service Introduction of GlaxoSmithKline Plc (UK)
Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Product and Service Introduction of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Company Profile and Development Status of Dendreon Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation (USA)
Figure Sales and Growth Rate Analysis of Dendreon Corporation (USA)
Figure Revenue and Market Share Analysis of Dendreon Corporation (USA)
Table Product and Service Introduction of Dendreon Corporation (USA)
-
